Quantcast

Latest Cerebral aneurysm Stories

2011-03-10 14:40:00

Option for those at greater risk for stroke during standard bypass surgery SILVER SPRING, Md., March 10, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a surgical kit that allows neurosurgeons to reroute blood flow around an aneurysm or a tumor in the brains of patients at greater risk of stroke during standard bypass surgery. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) The ELANA (Excimer Laser Assisted Non-Occlusive Anastamosis)...

2011-02-15 05:00:00

PALO ALTO, Calif., Feb. 15, 2011 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna(TM) Aneurysm Embolization System (AES) received CE Mark for the treatment of patients with brain aneurysms. The Luna AES is designed to be a single-deployment, easy-to-use system for the treatment of brain aneurysms both pre- and post-rupture. "Brain aneurysm treatment...

2011-01-11 09:00:00

PALO ALTO, Calif., Jan. 11, 2011 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, today announced that the company received U.S. Food and Drug Administration 510(k) clearance for its Acta(TM) Vessel Occlusion System (VOS). The Acta VOS provides physicians with a minimally-invasive alternative to current treatment options for an array of common and potentially serious vascular lesions. The...

2010-11-07 00:16:45

HCA Gulf Coast Division and The Joe Niekro Foundation present the second annual "Knuckle Ball"”A Pitch for Life" on Saturday, November 13th at Minute Maid Park. The event benefits The Joe Niekro Foundation funding education about brain aneurysms, aneurysm research and support for aneurysm patients and their families. Houston, TX (Vocus) November 4, 2010     HCA Gulf Coast Division and The Joe Niekro Foundation present the second annual "Knuckle Ball"”A Pitch...

2010-10-25 07:00:00

PALO ALTO, Calif., Oct. 25 /PRNewswire/ -- Nfocus Neuromedical Inc., an innovative medical device company focused on the next generation treatment for brain aneurysms, today announced the appointment of Eric Milledge to Chairman and CEO effective immediately. Milledge has served as the company's Chairman of the Board since April 2009. Former CEO, Martin Dieck, will assume the role of President and COO. Prior to joining Nfocus' Board, Milledge most recently served as Company Group...

2010-09-27 18:00:00

NEW BRUNSWICK, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke. Johnson & Johnson announced its agreement to acquire Micrus on July 12, 2010. Micrus Endovascular will operate under Codman Neurovascular, a business unit of Codman & Shurtleff, Inc., the global neurosurgery...

2010-09-20 15:35:29

The large Nordic twin study investigating the heritability of subarachnothe role of genetic factors underlying the development of SAH suggests that the role of genetic factors underlying the development of SAH is less than previously believed. The prevalence of subarachnoid haemorrhage (SAH) is almost three times as high in Finland and Japan as among other nationalities. In Finland, some 1,000 cases are diagnosed every year, with almost half of the cases ending in death. SAH predominantly...

2010-08-03 09:00:00

TUSTIN, Calif., Aug. 3 /PRNewswire/ -- MicroVention, Inc., a leading developer, manufacturer and marketer of interventional neurovascular devices, announced today that the final 18-month follow-up data in an international study showed that its innovative HydroCoil® Embolic System for treating cerebral aneurysms reduced recurrence and retreatment rates and provided improved outcomes in study patients when compared to bare platinum coils, which are considered the standard...

2010-08-02 15:44:04

Results from a new study suggest that oral contraceptives and hormone replacement therapy (HRT) may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women. The findings from this first-of-its-kind study by a neurointerventional expert from Rush University Medical Center were presented at the Society of Neurointerventional Surgery (SNIS) 7th annual meeting. According to the lead author of the study, Dr. Michael Chen, neurointerventionalist at Rush,...

2010-07-30 09:34:00

Findings Announced at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting CARLSBAD, Calif., July 30 /PRNewswire-USNewswire/ -- Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related